Ghemaxan

Ghemaxan is an anticoagulant medication containing Enoxaparin Sodium, used for preventing and treating blood clots. It is suitable for haemodialysis, intravenous, and subcutaneous use.

Ghemaxan is primarily used to prevent and treat blood clots in various medical conditions. It is often prescribed for patients undergoing haemodialysis or those at risk of deep vein thrombosis. Enoxaparin Sodium, the active ingredient, helps to thin the blood and reduce the risk of clotting. This medication is also used in surgical settings to prevent post-operative blood clots.

Common effects of Ghemaxan may include bruising, bleeding, and pain at the injection site. Some users might experience allergic reactions, although these are less frequent. It is important to monitor for any signs of unusual bleeding or bruising while using this medication.

Ghemaxan should be used with caution in patients with a history of bleeding disorders or kidney problems. It is essential to follow the prescribed dosage and administration instructions carefully. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Ghemaxan may interact with other blood-thinning medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Alcohol consumption should be limited as it can increase the risk of bleeding. Always consult a healthcare professional before combining Ghemaxan with other medications.